Wealth Enhancement Advisory Services, LLC Renalytix PLC Transaction History
Wealth Enhancement Advisory Services, LLC
- $46.2 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Renalytix PLC stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 63,739 shares of RNLX stock, worth $9,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,739
Previous 63,739
-0.0%
Holding current value
$9,560
Previous $13,000
30.77%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNLX
# of Institutions
8Shares Held
554KCall Options Held
0Put Options Held
0-
Gofen & Glossberg LLC188KShares$28,2330.01% of portfolio
-
Parian Global Management LP Pound Ridge, NY185KShares$27,7190.77% of portfolio
-
Cvi Holdings, LLC Wilmington, DE38.3KShares$5,7510.07% of portfolio
-
Xtx Topco LTD London, X032.8KShares$4,9160.0% of portfolio
-
Baader Bank Aktiengesellschaft Unterschleissheim, 2M24.3KShares$3,6430.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $5.62M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...